Systemic administration of β-glucan of 200 kDa modulates melanoma microenvironment and suppresses metastatic cancer-Reference-Cited by-同舟云学术

Systemic administration of β-glucan of 200 kDa modulates melanoma microenvironment and suppresses metastatic cancer

Published:2017-10-30 Issue:2 Volume:7 Page:e1387347
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Zhang Mei¹²,Chun Liane³^ORCID,Sandoval Victor⁴,Graor Hallie³,Myers Jay⁵,Nthale Joseph⁵,Rauhe Peter⁵^ORCID,Senders Zachary⁴,Choong Kevin⁴,Huang Alex Y.¹²⁵⁶,Kim Julian¹²³⁷

Affiliation:

1. Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, United States

2. Case Comprehensive Cancer Center, Cleveland, OH, United States

3. School of Medicine, Case Western Reserve University, Cleveland, OH, United States

4. Division of Surgical Oncology, University Hospitals, Cleveland, OH, United States

5. Division of Pediatric Hematology-Oncology, Department of Pediatrics, Case Western Reserve University; Angie Fowler AYA Cancer Institute, UH Rainbow Babies & Children's Hospital, Cleveland, OH, United States

6. Department of Pathology, Case Western Reserve University, Cleveland, OH, United States

7. Seidman Cancer Center, University Hospitals, Cleveland, OH, United States

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2017.1387347

Reference30 articles.

1. Cancer immunotherapy: moving beyond current vaccines

2. Immune resistance orchestrated by the tumor microenvironment

3. Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion